Palatin Technologies PTN
NASDAQ PTN
$9.69 -0.76 (-7.23%)
At close: Aug 21, 2026 · 4:00 PM EDT

Palatin Technologies (PTN) Income towards Parent Company (2010 - 2026)

Palatin Technologies' (PTN) quarterly Income towards Parent Company came in at -$1.4 million in Q1 2026, up 70.04% YoY from -$842719.1 in Q1 2025, and up 80.27% on a QoQ basis from -$7.3 million in Q4 2025.

Palatin Technologies (PTN) Income towards Parent Company (2010 - 2026) Analysis & Trends

Palatin Technologies (PTN) has 17 years of Income towards Parent Company data on file, last reported at -$1.4 million in Q1 2026.

  • Quarterly Income towards Parent Company rose 70.04% year-over-year to -$1.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$6.3 million (up 73.13% YoY) and the FY2025 annual result came in at -$87.6 million, down 194.57% from the prior year.
  • Income towards Parent Company improved to -$1.4 million in Q1 2026, from -$7.3 million in the prior quarter.
  • In the past five years, Income towards Parent Company ranged from a high of $4.7 million in Q3 2025 to a low of -$12.8 million in Q2 2022.
  • A 5-year average of -$5.7 million and a median of -$7.3 million in 2025 frame the typical range for Income towards Parent Company.
  • Annual changes were most pronounced in 2024 — Income towards Parent Company plunged 1657.47% — and 2025, when it soared 160.77%.
  • Tracing PTN's Income towards Parent Company over 5 years: stood at -$6.6 million in 2022, then fell by 18.09% to -$7.8 million in 2023, then surged by 67.03% to -$2.6 million in 2024, then plunged by 180.88% to -$7.3 million in 2025, then soared by 80.27% to -$1.4 million in 2026.
  • The last three Income towards Parent Company figures came in at -$1.4 million (Q1 2026), -$7.3 million (Q4 2025), and $4.7 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn
9 Royalty Pharma 27.27 Bn 26.43 Bn -
10 Palatin Technologies 40.37 Mn 40.37 Mn -

Historic Data

Download Data
DateValue
Mar 31, 2026 -1.43 Mn
Dec 31, 2025 -7.26 Mn
Sep 30, 2025 4.68 Mn
Jun 30, 2025 -2.25 Mn
Mar 31, 2025 -4.78 Mn
Dec 31, 2024 -2.59 Mn
Sep 30, 2024 -7.70 Mn
Jun 30, 2024 -8.25 Mn
Mar 31, 2024 -8.44 Mn
Dec 31, 2023 -7.84 Mn
Sep 30, 2023 -6.05 Mn
Jun 30, 2023 -469,449.00
Mar 31, 2023 -8.67 Mn
Dec 31, 2022 -6.64 Mn
Sep 30, 2022 -8.67 Mn
Jun 30, 2022 -12.77 Mn
Mar 31, 2022 -7.63 Mn
Dec 31, 2021 -8.69 Mn
Sep 30, 2021 -7.40 Mn
Jun 30, 2021 2.78 Mn